Effectiveness and safety of antithrombotic strategies in elderly patients with acute myocardial infarction

Table 3 Clinical outcomes, n (%)

Clinical outcomes	All	Pathology		P value
		STEMI	NSTEMI
Efficacy endpoint
In-hospital mortality	6/105 (5.7)	3/37 (8.1)	3/68 (4.4)	0.702
1-year MACEs1	7/90 (7.8)	4/32 (12.5)	3/58 (5.2)	0.457
Ischemic stroke	1/90 (1.1)	0/32	1/58 (1.7)	-
Cardiovascular death	3/90 (3.3)	2/32 (6.3)	1/58 (1.7)	-
Myocardial infarction	3/90 (3.3)	2/32 (6.3)	1/58 (1.7)	-
1-year non-cardiovascular death	11/90 (12.2)	6/32 (18.8)	5/58 (8.6)	0.369
Safety endpoint
In-hospital minor bleeding	2/105 (1.9)	0/37	2/68 (2.9)	0.834
In-hospital major bleeding	1/105 (1.0)	0/37	1/68 (1.5)	0.999
Minor bleeding after discharge1	9/90 (10)	3/32 (9.4)	6/58 (10.3)	0.999
Major bleeding after discharge1	2/90 (2.2)	0/32	2/58 (3.4)	0.846

¹1-year MACE and after-discharge bleeding events percentages refer to 90 patients (9 patients were lost to follow-up and 6 patients died during hospitalization). STEMI: ST-elevation myocardial infarction; NSTEMI: Non-ST-elevation myocardial infarction; MACEs: Major adverse cardiovascular events.